Healthpeak Properties (NYSE:DOC) Price Target Lowered to $19.00 at Evercore ISI

Healthpeak Properties (NYSE:DOC) had its price objective trimmed by Evercore ISI from $21.00 to $19.00 in a report released on Wednesday,Benzinga reports. The firm currently has an outperform rating on the real estate investment trust’s stock.

Several other research analysts also recently commented on the stock. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday. Jefferies Financial Group lowered Healthpeak Properties from a “buy” rating to a “hold” rating and cut their price target for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday, January 5th. Finally, The Goldman Sachs Group started coverage on Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 target price for the company. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and a consensus target price of $19.42.

Healthpeak Properties Stock Performance

Shares of DOC opened at $16.79 on Wednesday. Healthpeak Properties has a 1 year low of $15.71 and a 1 year high of $21.28. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.70 and a quick ratio of 1.22. The stock’s fifty day moving average price is $16.92 and its two-hundred day moving average price is $17.62. The firm has a market cap of $11.67 billion, a PE ratio of 167.92, a PEG ratio of 4.43 and a beta of 1.12.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. The company had revenue of $719.40 million during the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities research analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.3%. Healthpeak Properties’s dividend payout ratio (DPR) is 1,220.00%.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds have recently added to or reduced their stakes in the company. Mather Group LLC. purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $25,000. City Holding Co. bought a new position in Healthpeak Properties during the third quarter valued at approximately $26,000. Sound Income Strategies LLC purchased a new position in shares of Healthpeak Properties during the third quarter worth approximately $28,000. Rexford Capital Inc. bought a new stake in shares of Healthpeak Properties in the 2nd quarter worth approximately $28,000. Finally, WPG Advisers LLC boosted its stake in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.